Early results of an NCI-sponsored Phase II study of 18F-fluoroestradiol (FES) PET imaging of metastatic breast cancer (MBC)

被引：0
|
作者：
Peterson, Lanell [1 ]
Kurland, Brenda [4 ]
Linden, Hannah [2 ]
Link, Jeanne [3 ]
Schubert, Erin [1 ]
Gadi, Vijayakrishna [2 ]
Specht, Jennifer [2 ]
Eary, Janet [3 ]
Shankar, Lalitha [5 ]
Mankoff, David [1 ]
机构：
[1] Univ Washington, Med Ctr, Seattle Canc Care Alliance, Radiol Nucl Med, Seattle, WA 98195 USA
[2] Univ Washington, Med Ctr, Seattle Canc Care Alliance, Med Oncol, Seattle, WA 98195 USA
[3] Univ Washington, Med Ctr, Radiol Nucl Med, Seattle, WA 98195 USA
[4] Fred Hutchinson Canc Res Ctr, Clin Stat, Seattle, WA 98104 USA
[5] NCI, Canc Imaging Program, Bethesda, MD 20892 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
329
引用
收藏
页数：2
相关论文
共 50 条
  • [21] DEVELOPMENT OF QUALITY CONTROL METHOD FOR EVALUATION OF IN HOUSE PRODUCTION OF 18F-FLUOROESTRADIOL (FES) A PET ESTROGEN RECEPTOR IMAGING LIGAND
    Young, K.
    Veamatahau, A.
    Ackermann, U.
    Scott, A. M.
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 10 - 10
  • [22] [18F] fluoroestradiol (FES) PET as a predictive measure for endocrine therapy in women with newly diagnosed metastatic breast cancer
    Linden, Hannah
    Clark, Amy
    Fowler, Amy
    Novakova, Alena
    Mankoff, David
    Dehdashti, Farrokh
    CANCER RESEARCH, 2018, 78 (04)
  • [23] The heterogeneity of estrogen receptor (ER) expression in metastatic breast cancer is measured by [18F]-fluoroestradiol (FES) PET.
    Mankoff, DA
    Tewson, TJ
    Peterson, LM
    Stekhova, S
    Gralow, JR
    Livingston, RB
    Moe, RE
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 28P - 28P
  • [24] The predictive value of early changes in 18F-fluoroestradiol PET/CT during fulvestrant 500 mg therapy in patients with ER-positive metastatic breast cancer
    He, M.
    Liu, C.
    Yang, Z. -Y.
    Liu, G. -Y.
    Zhang, Y. -J.
    Wang, Z. -H.
    Shao, Z. -M.
    BREAST, 2019, 44 : S58 - S58
  • [25] A metastatic, cutaneous mucinous carcinoma revealed by the 16α-18F-fluoroestradiol (18F-FES) PET/CT scan and successfully treated by hormonotherapy: Description of a case report
    Longo, Raffaele
    Ben Mammoud, Sinan
    Ribal, Romane
    Dadoun, Alexandre
    Egea, Julie
    Plastino, Francesca
    Legros, Pierre-Olivier
    Marcon, Nathalie
    Liegeon, Anne Laure
    Campitiello, Marco
    JOURNAL OF DERMATOLOGY, 2024, 51 (06): : e205 - e206
  • [26] Early prediction of efficacy of endocrine therapy in breast cancer (BC): Pilot study and validation with 18F fluoroestradiol (18F-FES) PET/CT.
    Gennari, Alessandra
    Amadori, Dino
    Brain, Etienne
    Cortes, Javier
    Harbeck, Nadia
    Puntoni, Matteo
    Wuerstlein, Rachel
    Nanni, Oriana
    Munoz-Couselo, Eva
    Paganelli, Giovanni
    Sierra, Maribel Lopera
    Matteucci, Federica
    Piccardo, Arnaldo
    Bruzzi, Paolo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Clinical production, stability studies and PET imaging with 16α-[18F] fluoroestradiol([18F]FES) in ER positive breast cancer patients
    Kumar, Piyush
    Mercer, John
    Doerkson, Courtney
    Tonkin, Katia
    McEwan, Alexander J. B.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2007, 10 (02): : 256 - 265
  • [28] 18F-Fluoroestradiol PET/CT for Staging Low-Grade Estrogen Receptor-Positive Breast Cancer
    Fowler, Amy M.
    RADIOLOGY, 2025, 314 (03)
  • [29] Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression
    Currin, Erin
    Peterson, Lanell M.
    Schubert, Erin K.
    Link, Jeanne M.
    Krohn, Kenneth A.
    Livingston, Robert B.
    Mankoff, David A.
    Linden, Hannah M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (02): : 144 - 147
  • [30] Automated Lesion Detection for 18F-Fluoroestradiol PET/CT Images Demonstrates Lesion Heterogeneity in Patients with ER plus Metastatic Breast
    Battle, M.
    Wangerin, K.
    Miller, R.
    Houshmandi, S. S.
    Huff, D. T.
    Weisman, A. J.
    Perk, T. G.
    Ulaner, G. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S475 - S476
12345